Stock News - Denali Therapeutics Inc. $DNLI
Latest Stock News for $DNLI
Denali Therapeutics Terminates Collaboration Agreement with Takeda for DNL593
Expected Stock impact: Slightly Negative
2026-04-03 18:44:52
Denali Therapeutics Secures $200 Million in Royalty Agreement Following FDA Approval
Expected Stock impact: Very Positive
2026-03-31 12:30:59
Denali Therapeutics Receives FDA Approval for AVLAYAH™ to Treat Hunter Syndrome
Expected Stock impact: Very Positive
2026-03-25 19:14:08
